Question 1

Has Maanasa Indaram, MD received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $25,083 in general payments to Maanasa Indaram, MD across 38 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Maanasa Indaram, MD did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Maanasa Indaram, MD come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Glaukos Corporation	19	$19,016
Amgen(2 entities)	10	$3,150
Luminopia, Inc.	2	$2,419
Coopervision Inc.	3	$344
Ocular Therapeutix, Inc.	4	$154

Maanasa Indaram, MD

Payments from drug & device makers

Who reported the general payments

What the payments were tied to

How this compares

Medicare billing

Other ophthalmology in San Francisco